CXCL12 and acute myeloid leukemia: Similar observations were recently reported for acute myelogenous leukemia in which antagonism of CXCL12 resulted in leukemic blast mobilization from the bone marrow and enhanced anti-leukemia effect of tyrosine kinase inhibitors [59].